Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Premier Biomedical, Inc. (BIEI)
USD0.00
+0.00 (+38.46%)
US OTC Healthcare Medical - Pharmaceuticals
Address
PO Box 25 16133
Knoxville, PA, US
Knoxville, PA, US
CEO
David Caplan
Website
premierbiomedical.com
IPO
2012-08-15
CIK 1515740 ISIN US74048K2033
Description
Premier Biomedical, Inc. functions as a company primarily focused on research, actively involved in both the genesis and identification of innovative medical offerings. The firm specifically directs its efforts toward formulating and disseminating topical pain management solutions that incorporate hemp oil. Established by Mitchell S. Felder on May 10, 2010, the company's central operations are based in Knoxville, Tennessee.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+38.46%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
29M
Beta
0.74
Float Shares
976.30M
Free Float %
97.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.34% | -13.33% | +50.29% | +140.74% | +116.67% | +188.89% | +160.00% | +95.49% | -18.75% | -93.95% | -99.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-8,931.36
Distress
Piotroski F-Score
0 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%—
-
EPS growth Medical - Pharmaceuticals: +20.2%+200.0% ★
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%—
-
EBIT margin Medical - Pharmaceuticals: +6.8%—
-
ROIC Medical - Pharmaceuticals: +6.1%— Q1'26: +2.9% (vs Q1'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+18.3% Q1'26: +16.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×-8.58× Q1'26: -13.98× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-190.5K
OE per share TTM
0.00
Owner's Yield
-10.47%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
180.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
20.00M
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+20,000,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-27 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 2,000,000 | 0.00 | 2.6K | 18,334,488 | — | ↗ |
| 2020-03-26 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000,000 | 0.00 | 4.5K | 16,334,488 | — | ↗ |
| 2020-02-04 | Borza John Stanley | Director / Officer | P-Purchase | A | Common Stock | 5,000,000 | 0.00 | 1.5K | 5,004,224 | — | ↗ |
| 2020-02-03 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | Common stock | 10,000,000 | 0.00 | 3.0K | 13,334,488 | — | ↗ |
| 2019-09-16 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | common stock | 168,845 | 0.01 | 1.7K | 2,934,388 | — | ↗ |
| 2019-09-11 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 30,250 | 0.01 | 248.05 | 2,008,281 | — | ↗ |
| 2019-08-07 | FELDER MITCHELL S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 257,644 | 0.01 | 1.9K | 1,328,031 | — | ↗ |
| 2018-12-20 | Reyes Patricio F | Director / Officer | A-Award | A | Warrant (right to buy) | 500,000 | 0.09 | 45.0K | 500,000 | — | ↗ |
| 2018-12-20 | ROSEN JAY PRESTON | Director | A-Award | A | Warrant (right to buy) | 52,500 | 0.09 | 4.7K | 52,500 | — | ↗ |
| 2018-12-20 | PAULY JOHN C | Director | A-Award | A | Warrant (right to buy) | 52,500 | 0.09 | 4.7K | 52,500 | — | ↗ |
| 2018-12-20 | Hartman William A. | Director / Officer | A-Award | A | Warrant (right to buy) | 842,000 | 0.09 | 75.8K | 842,000 | — | ↗ |
| 2018-12-20 | FELDER MITCHELL S | Director / 10% Owner | A-Award | A | Warrant (right to buy) | 842,000 | 1.25 | 1.05M | 842,000 | — | ↗ |
| 2018-12-20 | Carl Heidi H. | Director / Officer | A-Award | A | Warrant (right to buy) | 500,000 | 0.09 | 45.0K | 500,000 | — | ↗ |
| 2018-12-20 | Borza John Stanley | Director / Officer | A-Award | A | Warrant (right to buy) | 579,000 | 0.09 | 52.1K | 579,000 | — | ↗ |
| 2018-11-05 | FELDER MITCHELL S | Director / 10% Owner | M-Exempt | A | Common Stock | 12,000 | 0.00 | 30.00 | 77,031 | — | ↗ |
| 2017-12-22 | Reyes Patricio F | Director / Officer | A-Award | A | Warrant (right to buy) | 4,000,000 | 0.01 | 20.0K | 4,000,000 | — | ↗ |
| 2017-12-22 | ROSEN JAY PRESTON | Director | A-Award | A | Warrant (right to buy) | 1,000,000 | 0.01 | 5.0K | 1,000,000 | — | ↗ |
| 2017-12-22 | PAULY JOHN C | Director | A-Award | A | Warrant (right to buy) | 2,000,000 | 0.01 | 10.0K | 2,000,000 | — | ↗ |
| 2017-12-22 | Hartman William A. | Director / Officer | A-Award | A | Warrant (right to buy) | 8,500,000 | 0.01 | 42.5K | 8,500,000 | — | ↗ |
| 2017-12-22 | FELDER MITCHELL S | Director | A-Award | A | Warrant (right to buy) | 8,500,000 | 0.01 | 42.5K | 8,500,000 | — | ↗ |
| 2017-12-22 | Carl Heidi H. | Director / Officer | A-Award | A | Warrant (right to buy) | 6,000,000 | 0.01 | 30.0K | 6,000,000 | — | ↗ |
| 2017-12-22 | Borza John Stanley | Director / Officer | A-Award | A | Warrant (right to buy) | 7,250,000 | 0.01 | 36.3K | 7,250,000 | — | ↗ |
| 2017-12-07 | PAULY JOHN C | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-11-22 | Hartman William A. | Director / Officer / 10% Owner | M-Exempt | D | Warrant (right to buy) | 7,000,000 | 0.00 | — | 0 | — | ↗ |
| 2016-12-20 | Hartman William A. | Director / Officer / 10% Owner | M-Exempt | D | Warrant (right to buy) | 6,000,000 | 0.00 | — | 11,000,000 | — | ↗ |
| 2016-12-20 | FELDER MITCHELL S | Director / 10% Owner | M-Exempt | A | Common Stock | 6,000,000 | 0.00 | — | 12,257,672 | — | ↗ |
| 2016-08-22 | Reyes Patricio F | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 120,000 | — | ↗ |
| 2016-08-19 | Hartman William A. | Director / Officer / 10% Owner | M-Exempt | D | Warrant (right to buy) | 4,000,000 | 0.00 | — | 13,000,000 | — | ↗ |
| 2016-08-19 | FELDER MITCHELL S | Director / 10% Owner | M-Exempt | D | Warrant (right to buy) | 4,000,000 | 0.00 | — | 9,000,000 | — | ↗ |
| 2016-06-15 | Reyes Patricio F | Director / Officer | — | D | Common Stock Warrants | 350,000 | 0.05 | 17.5K | 0 | — | ↗ |
| 2016-01-29 | Hartman William A. | Director / Officer / 10% Owner | M-Exempt | D | Warrant (right to buy) | 1,000,000 | 0.00 | 1.0K | 0 | — | ↗ |
| 2016-01-29 | FELDER MITCHELL S | Director / 10% Owner | M-Exempt | D | Warrant (right to buy) | 1,000,000 | 0.00 | 1.0K | 0 | — | ↗ |
| 2015-10-21 | ROSEN JAY PRESTON | Director | J-Other | A | Warrant (right to buy) | 200,000 | 0.05 | 10.0K | 200,000 | — | ↗ |
| 2015-10-21 | Najarian Richard Thomas | Director / 10% Owner | J-Other | A | Warrant (right to buy) | 200,000 | 0.05 | 10.0K | 200,000 | — | ↗ |
| 2015-10-21 | Hartman William A. | Director / Officer / 10% Owner | J-Other | A | Warrant (right to buy) | 1,000,000 | 0.05 | 50.0K | 1,000,000 | — | ↗ |
| 2015-10-21 | FELDER MITCHELL S | Director / Officer / 10% Owner | J-Other | A | Warrant (right to buy) | 1,000,000 | 0.05 | 50.0K | 1,000,000 | — | ↗ |
| 2015-10-21 | Carl Heidi H. | Director / Officer | J-Other | A | Warrant (right to buy) | 750,000 | 0.05 | 37.5K | 750,000 | — | ↗ |
| 2015-10-21 | Borza John Stanley | Director / 10% Owner | J-Other | A | Warrant (right to buy) | 600,000 | 0.05 | 30.0K | 600,000 | — | ↗ |
| 2015-10-01 | FELDER MITCHELL S | Officer | M-Exempt | A | Warrant (right to buy) | 3,000,000 | 0.00 | — | 13,000,000 | — | ↗ |
| 2015-09-28 | FELDER MITCHELL S | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 250,000 | 0.00 | — | 3,703,944 | — | ↗ |
| 2015-09-28 | FELDER JUSTIN ANDREW | — | G-Gift | A | Premier Biomedical, Inc. (BIEI) | 250,000 | 0.00 | — | 1,011,297 | — | ↗ |
| 2015-09-08 | FELDER MITCHELL S | Director / 10% Owner | M-Exempt | A | Common Stock | 1,000,000 | 0.00 | — | 4,453,944 | — | ↗ |
| 2015-06-25 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 30,000 | 0.11 | 3.3K | 761,297 | — | ↗ |
| 2015-06-23 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 23,000 | 0.10 | 2.3K | 791,297 | — | ↗ |
| 2015-06-22 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 10,000 | 0.12 | 1.2K | 814,297 | — | ↗ |
| 2015-06-09 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 7,000 | 0.14 | 949.90 | 824,297 | — | ↗ |
| 2015-06-02 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 2,570 | 0.14 | 359.80 | 831,297 | — | ↗ |
| 2015-06-01 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 8,730 | 0.14 | 1.2K | 833,867 | — | ↗ |
| 2015-05-28 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 2,300 | 0.14 | 319.70 | 842,597 | — | ↗ |
| 2015-05-27 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 5,750 | 0.14 | 799.25 | 844,897 | — | ↗ |
| 2015-05-26 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 6,086 | 0.14 | 845.95 | 850,647 | — | ↗ |
| 2015-05-19 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 9,564 | 0.13 | 1.2K | 856,733 | — | ↗ |
| 2015-05-14 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Premier Biomedical, Inc. (BIEI) | 45,000 | 0.11 | 5.0K | 866,297 | — | ↗ |
| 2015-01-15 | Reyes Patricio F | Director / Officer | — | D | Common Stock Warrants | 700,000 | 0.25 | 175.0K | 0 | — | ↗ |
| 2014-12-10 | ROSEN JAY PRESTON | Director | P-Purchase | A | Warrant | 400,000 | 0.25 | 100.0K | 400,000 | — | ↗ |
| 2014-12-10 | Najarian Richard Thomas | Director / 10% Owner | P-Purchase | A | Warrant | 1,200,000 | 0.25 | 300.0K | 1,200,000 | — | ↗ |
| 2014-12-10 | Hartman William A. | Director / Officer / 10% Owner | P-Purchase | A | Warrant | 1,600,000 | 0.25 | 400.0K | 1,600,000 | — | ↗ |
| 2014-12-10 | FELDER MITCHELL S | Director / 10% Owner | P-Purchase | A | Warrant | 1,600,000 | 0.25 | 400.0K | 1,600,000 | — | ↗ |
| 2014-12-10 | FELDER JUSTIN ANDREW | Director | P-Purchase | A | Warrant | 1,200,000 | 0.25 | 300.0K | 1,200,000 | — | ↗ |
| 2014-12-10 | Carl Heidi H. | Director / Officer | P-Purchase | A | Warrant | 1,400,000 | 0.25 | 350.0K | 1,400,000 | — | ↗ |
| 2014-12-10 | Borza John Stanley | Director | P-Purchase | A | Warrant | 1,200,000 | 0.25 | 300.0K | 1,200,000 | — | ↗ |
| 2014-03-31 | Borza John Stanley | Director | J-Other | A | Common Stock | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2014-02-12 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 51,653 | 1.64 | 84.7K | 911,297 | — | ↗ |
| 2013-09-25 | Najarian Richard Thomas | Director | A-Award | A | Common Stock | 1,000,000 | 0.05 | 50.0K | 2,520,000 | — | ↗ |
| 2013-09-24 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 6,000 | 0.50 | 3.0K | 962,950 | — | ↗ |
| 2013-08-20 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 1,000 | 0.80 | 800.00 | 968,950 | — | ↗ |
| 2013-08-13 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 2,500 | 0.75 | 1.9K | 969,950 | — | ↗ |
| 2013-07-09 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 24,000 | 0.50 | 12.0K | 975,450 | — | ↗ |
| 2013-07-02 | Borza John Stanley | Director | C-Conversion | A | Common Stock | 6,000 | 0.50 | 3.0K | 1,036,000 | — | ↗ |
| 2013-06-25 | FELDER MITCHELL S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 46,056 | 1.09 | 50.2K | 3,453,944 | — | ↗ |
| 2013-06-21 | Borza John Stanley | Director | C-Conversion | A | Common Stock | 10,000 | 0.10 | 1.0K | 20,000 | — | ↗ |
| 2013-06-13 | FELDER JUSTIN ANDREW | Director | S-Sale | D | Common Stock | 550 | 0.90 | 495.00 | 999,450 | — | ↗ |
| 2013-03-15 | Borza John Stanley | Director | J-Other | D | Warrant | 1,250 | 0.10 | 125.00 | 0 | — | ↗ |
| 2013-02-25 | FELDER MITCHELL S | Director / Officer / 10% Owner | A-Award | A | Common Stock | 500,000 | 0.05 | 25.0K | 3,500,000 | — | ↗ |
| 2013-02-20 | Najarian Richard Thomas | Director | A-Award | A | Common Stock | 1,500,000 | 0.05 | 75.0K | 1,520,000 | — | ↗ |
| 2013-02-20 | Borza John Stanley | Director | A-Award | A | Common Stock | 1,000,000 | 0.05 | 50.0K | 1,020,000 | — | ↗ |
| 2012-10-08 | ROSEN JAY PRESTON | Director | A-Award | A | Common Stock Warrant | 50,000 | 1.45 | 72.5K | 50,000 | — | ↗ |
| 2012-10-08 | Najarian Richard Thomas | Director | A-Award | A | Common Stock Warrant | 1,120,000 | 1.45 | 1.62M | 1,160,000 | — | ↗ |
| 2012-10-08 | Hartman William A. | Director / Officer / 10% Owner | A-Award | A | Common Stock Warrant | 155,000 | 1.45 | 224.8K | 17,155,000 | — | ↗ |
| 2012-10-08 | FOLTZ RAMON DOYLE | Director | A-Award | A | Common Stock Warrant | 50,000 | 1.45 | 72.5K | 50,000 | — | ↗ |
| 2012-10-08 | FELDER MITCHELL S | Director / Officer / 10% Owner | A-Award | A | Common Stock Warrant | 155,000 | 1.45 | 224.8K | 17,155,000 | — | ↗ |
| 2012-10-08 | FELDER JUSTIN ANDREW | Director | A-Award | A | Common Stock Warrant | 50,000 | 1.45 | 72.5K | 50,000 | — | ↗ |
| 2012-10-08 | Carl Heidi H. | Director / Officer | A-Award | A | Common Stock Warrant | 120,000 | 1.45 | 174.0K | 120,000 | — | ↗ |
| 2012-10-08 | Borza John Stanley | Director | A-Award | A | Common Stock Warrant | 1,120,000 | 1.45 | 1.62M | 1,147,250 | — | ↗ |
| 2012-10-08 | BARNES SCOTT MARTIN | Director | A-Award | A | Common Stock Warrant | 50,000 | 1.45 | 72.5K | 50,000 | — | ↗ |
| 2012-08-17 | Najarian Richard Thomas | Director | — | D | Common Stock | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2012-08-17 | Borza John Stanley | Director | — | I | Common Stock | 0 | 0.00 | — | 25,250 | — | ↗ |
| 2012-08-16 | Borza John Stanley | Director | P-Purchase | A | Common Stock | 6,000 | 0.50 | 3.0K | 31,250 | — | ↗ |
| 2012-06-30 | LEBRECHT GROUP APLC | 10% Owner | J-Other | A | Common Stock Purchase Warrant | 2,500,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2011-12-13 | ROSEN JAY PRESTON | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2011-12-13 | Hartman William A. | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,000,000 | — | ↗ |
| 2011-12-13 | FOLTZ RAMON DOYLE | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2011-12-13 | FELDER MITCHELL S | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,000,000 | — | ↗ |
| 2011-12-13 | FELDER JUSTIN ANDREW | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2011-12-13 | Carl Heidi H. | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2011-02-25 | Najarian Richard Thomas | Director | — | I | Common Stock Warrant | 10,000 | 0.10 | 1.0K | 0 | — | ↗ |
| 2011-02-12 | Borza John Stanley | Director | — | I | Common Stock Warrant | 21,250 | 0.10 | 2.1K | 0 | — | ↗ |
| 2010-06-21 | LEBRECHT GROUP APLC | 10% Owner | — | D | Common Stock Warrants | 2,500,000 | 0.00 | — | 0 | — | ↗ |
| 2010-06-21 | Hartman William A. | Director / Officer / 10% Owner | — | D | Series A Convertible Preferred Stock Warrants | 1,000,000 | 0.00 | 100.00 | 0 | — | ↗ |
| 2010-06-21 | FELDER MITCHELL S | Director / Officer / 10% Owner | — | D | Common Stock Warrants | 17,000,000 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
999.98M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carl Eller | Marketing & Planning Vice-President | — | male |
| David Caplan | President, Chairman of the Board of Directors, Secretary & Treasurer | — | male |
| Gustavo Carreño | Chief Technology Officer | — | male |
ESG Rating
ESG Score History INDUSTRIAL MATERIALS
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BIEI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
